AGP Picks View all

Pozitivf Fertility pledges affordable IVF as U.S. birth rates hit a record low

Jun. 19, 2026

Pozitivf Fertility said it is recommitting to affordable IVF in Texas as new federal data show U.S. birth rates fell to a record low in 2025. The company says the main barrier is cost, and it plans to expand later in 2026 to reach more patients in Houston, San Antonio, El Paso and the Rio Grande Valley. Why it matters: - U.S. birth rates fell to a record low of 53.1 births per 1,000 women in 2025, extending a nearly two-decade decline. - Pozitivf Fertility says many women still want children, but delayed family planning and high IVF costs keep treatment out of reach. - The company is positioning affordable fertility care as a practical response to a national birth-rate problem. What happened: - Pozitivf Fertility publicly reaffirmed its mission to make IVF accessible and affordable for families in Texas, regardless of income, background or insurance status. - The Houston- and San Antonio-based fertility network said it is using a fully self-pay model with transparent upfront pricing and financing options. - Dr. Francisco (Paco) Arredondo, chief medical officer of Pozitivf Fertility, said too many fertility journeys end when patients face a $30,000 price tag at a traditional clinic. - Luis Alberto Perez, associated with Pozitivf Fertility, said the fertility industry has not sufficiently addressed affordability as a barrier to family formation. The details: - Pozitivf says it offers evidence-based IVF protocols similar to larger academic fertility centers. - The clinic says its model avoids overhead, wait times and billing complexity that can raise costs at traditional practices. - The company says demand at its Texas locations continues to grow significantly year over year. - Pozitivf currently serves patients in Houston and San Antonio. - Consultations are available in English and Spanish. - Patients do not need a referral. - The company said expansion is planned for later in 2026 in El Paso and the Rio Grande Valley. - Pozitivf says each patient receives a dedicated fertility advocate. - The company says its care model is built around transparent pricing and streamlined service. - More information is available at the company’s announcement . - Pozitivf also shared social accounts at LinkedIn , Instagram , Facebook and YouTube . Between the lines: - The release frames low birth rates less as a lack of desire for children and more as a timing and affordability problem. - Pozitivf is betting that lower-cost IVF can capture patients who want treatment but have been priced out of the market. - The message also signals a broader push to connect fertility access with demographic concerns. What’s next: - Pozitivf plans to expand into El Paso and the Rio Grande Valley later in 2026. - The company is likely to continue leaning on affordability, self-pay pricing and bilingual access as it grows. - The longer-term test will be whether lower prices and simpler access can meaningfully widen IVF use for Texas families.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

American Times Reporter

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

American Times Reporter

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.